{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Lingling Xu",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "path": "antalarmin/dinopoulou2013.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "At all embryo stages, significant differences were noted between the CRH 10􏰁7 and control groups as well as be- tween the CRH 10􏰁7 and CRH 10􏰁7/antalarmin 10􏰁6 groups, with the rates being lower in the former. ",
      "key": "b73fce724340c4d97c4234f7cbb76641",
      "line": 76,
      "relation": "increases",
      "source": 5,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "With regard to the morula/blastocyst stage, the rates in the CRH 10􏰁7 group were lower compared with the control (P 􏰄 0.003) and lower compared with the CRH 10􏰁7/antalarmin 10􏰁6 group (P 􏰃 0.001) (Table 2).",
      "key": "e72cb47ece351dce266e97e7a8ace3d5",
      "line": 84,
      "relation": "increases",
      "source": 5,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "With regard to the morula/blastocyst stage, the rates in the CRH 10􏰁7 group were lower compared with the control (P 􏰄 0.003) and lower compared with the CRH 10􏰁7/antalarmin 10􏰁6 group (P 􏰃 0.001) (Table 2).",
      "key": "61ada648cd5425a0dac253beb3b0e060",
      "line": 85,
      "relation": "increases",
      "source": 5,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "Interestingly, the addition of a 10-fold excess of the CRH-R1 antagonist, antalarmin, overcame the negative effect of CRH on estradiol release (d 5, P 􏰄 0.009; d 7, P 􏰄 0.010; d 9, P 􏰃 0.001; and d 11, P 􏰄 0.002), indicating that the suppressive effect of CRH was receptor mediated (Fig. 1).",
      "key": "29c7dd65c78b087233ea54de1a72e3db",
      "line": 91,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on beta􏰇-hCG release (d 11 beta􏰇-hCG 185.6 􏰅 6.087 mIU/ml, P 􏰃 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3).",
      "key": "d0a86696b24ad835b973c8fb17133745",
      "line": 98,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "The addition of a 10-fold excess of the CRH-R1 antagonist antalarmin reversed the negative ef- fect of CRH on progesterone release (d 11 progesterone 0.712 􏰅 0.004 ng/ml, P 􏰃 0.001), suggesting that the suppressive effect of CRH was receptor mediated (Fig. 2).",
      "key": "f2943817a7ab805e2e2b879a8388025b",
      "line": 112,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 8
    },
    {
      "key": "0986261fdbd8820a6a9f1aedfa4f1f26",
      "relation": "partOf",
      "source": 5,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "Interestingly, the addition of a 10-fold excess of the CRH-R1 antagonist, antalarmin, overcame the negative effect of CRH on estradiol release (d 5, P 􏰄 0.009; d 7, P 􏰄 0.010; d 9, P 􏰃 0.001; and d 11, P 􏰄 0.002), indicating that the suppressive effect of CRH was receptor mediated (Fig. 1).",
      "key": "1c899b1f17bfefec54429c27534192ee",
      "line": 90,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 8,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on beta􏰇-hCG release (d 11 beta􏰇-hCG 185.6 􏰅 6.087 mIU/ml, P 􏰃 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3).",
      "key": "6a84d100853b87429ac239a0fd52d5c5",
      "line": 97,
      "relation": "regulates",
      "source": 8,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "In the CRH 10􏰁7 mol/liter group, the amount of beta􏰇-hCG measured in the culture medium was elevated but to a lesser extent compared with the control group (d 11 􏰇-hCG 6.05 􏰅 0.077 mIU/ml, P 􏰃 0.001). ",
      "key": "4e0d66a576e4ad6d234dabe6c5430f74",
      "line": 118,
      "relation": "decreases",
      "source": 8,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "Notably, CRH did not affect the amount of progesterone released into the incubation medium up to d 9, whereas it suppressed pro- gesterone levels on d 11 (d 11 progesterone 0.030 􏰅 0.000 ng/ml, P 􏰃 0.001). ",
      "key": "bb905f970a6e16cda72472613b3eb1b5",
      "line": 105,
      "relation": "causesNoChange",
      "source": 8,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "Notably, CRH did not affect the amount of progesterone released into the incubation medium up to d 9, whereas it suppressed pro- gesterone levels on d 11 (d 11 progesterone 0.030 􏰅 0.000 ng/ml, P 􏰃 0.001). ",
      "key": "94da4d7fcc2278e10a3eb67d49e52b69",
      "line": 107,
      "relation": "decreases",
      "source": 8,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "The addition of a 10-fold excess of the CRH-R1 antagonist antalarmin reversed the negative ef- fect of CRH on progesterone release (d 11 progesterone 0.712 􏰅 0.004 ng/ml, P 􏰃 0.001), suggesting that the suppressive effect of CRH was receptor mediated (Fig. 2).",
      "key": "909c97d97d4449f4721a491ccae60f9f",
      "line": 113,
      "relation": "decreases",
      "source": 8,
      "target": 4
    },
    {
      "key": "b27ad274bd3c0f6f45fe394a4de80143",
      "relation": "partOf",
      "source": 8,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Anagnostou E",
          "Chrousos GP",
          "Dinopoulou V",
          "Drakakis P",
          "Loutradis D",
          "Makrigiannakis A",
          "Mavrogianni D",
          "Partsinevelos GA"
        ],
        "date": "2013-01-01",
        "db": "PubMed",
        "db_id": "23211705",
        "db_name": "The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.",
        "first": "Dinopoulou V",
        "journal": "Endocrinology",
        "last": "Loutradis D",
        "pages": "222-31",
        "volume": "154"
      },
      "evidence": "The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on 􏰇-hCG release (d 11 beta􏰇-hCG 185.6 􏰅 6.087 mIU/ml, P 􏰃 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3).",
      "key": "de8887c88ede8d18dbb43d952b4d497b",
      "line": 123,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 6,
      "target": 7
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(MESH:\"Embryonic Structures\")",
      "concept": {
        "name": "Embryonic Structures",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "b8c3fcc99e26547feb53c46eff0c8301"
    },
    {
      "bel": "a(MESH:Blastocyst)",
      "concept": {
        "name": "Blastocyst",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f623452d312e489a63176bd0e0098a4f"
    },
    {
      "bel": "a(MESH:Estradiol)",
      "concept": {
        "name": "Estradiol",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9494f93d32defedd3cea86cd37f41422"
    },
    {
      "bel": "a(MESH:Morula)",
      "concept": {
        "name": "Morula",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "cbb6c3287dbe8b4deedfb3aa5fe4d5a5"
    },
    {
      "bel": "a(MESH:Progesterone)",
      "concept": {
        "name": "Progesterone",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1d0bf9abc0b5267128483475891c6918"
    },
    {
      "bel": "a(MESH:antalarmin)",
      "concept": {
        "name": "antalarmin",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9142608fdaf13e5d3f2f3fd152de1479"
    },
    {
      "bel": "composite(a(MESH:antalarmin), p(MGI:Crh))",
      "function": "Composite",
      "id": "d793b21950269cc5ad8e2a9ac6d68e55",
      "members": [
        {
          "bel": "a(MESH:antalarmin)",
          "concept": {
            "name": "antalarmin",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "9142608fdaf13e5d3f2f3fd152de1479"
        },
        {
          "bel": "p(MGI:Crh)",
          "concept": {
            "name": "Crh",
            "namespace": "MGI"
          },
          "function": "Protein",
          "id": "090e464a67a6f7d425e48ae5517e67d6"
        }
      ]
    },
    {
      "bel": "p(HGNC:CGB3)",
      "concept": {
        "name": "CGB3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "38640ad420de6ef16cea7e9547c83d05"
    },
    {
      "bel": "p(MGI:Crh)",
      "concept": {
        "name": "Crh",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "090e464a67a6f7d425e48ae5517e67d6"
    },
    {
      "bel": "p(MGI:Crhr1)",
      "concept": {
        "name": "Crhr1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "d546c940f3bd76fe51b9ac461f83de98"
    }
  ]
}